Day One Biopharmaceuticals, Inc. (DAWN)

DAWN Revenue

Day One Biopharmaceuticals had revenue of $93.76M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $101.95M.

• Revenue (ttm): $101.95M
• Revenue Growth: n/a
• P/S Ratio: 11.18
• Revenue / Employee: $657,761
• Employees: 155
• Market Cap: 1.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.